Atossa Therapeutics (Germany) Today
Atossa Therapeutics is selling for under 0.96 as of the 26th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.96. Equity ratings for Atossa Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Valuation
Check how we calculate scores
Atossa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Atossa Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Atossa Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Atossa Therapeutics (YAG2) is traded on Stuttgart Exchange in Germany and employs 6 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atossa Therapeutics's market, we take the total number of its shares issued and multiply it by Atossa Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Atossa Therapeutics operates under Healthcare sector and is part of Biotechnology industry. The entity has 126.62 M outstanding shares.
Atossa Therapeutics generates negative cash flow from operations
Check Atossa Therapeutics Probability Of Bankruptcy
Atossa Stock Against Markets
Atossa Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atossa Therapeutics stock to make a market-neutral strategy. Peer analysis of Atossa Therapeutics could also be used in its relative valuation, which is a method of valuing Atossa Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Atossa Therapeutics Corporate Management
Elected by the shareholders, the Atossa Therapeutics' board of directors comprises two types of representatives: Atossa Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atossa. The board's role is to monitor Atossa Therapeutics' management team and ensure that shareholders' interests are well served. Atossa Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atossa Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Heather Rees | VP Accounting | Profile | |
| FCAP MD | CEO Chairman | Profile | |
| Delly PHR | VP HR | Profile | |
| RAC MSPH | Quality Regulatory | Profile | |
| Richard MD | Interim Officer | Profile | |
| CPA Esq | Gen CFO | Profile |
Additional Tools for Atossa Stock Analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.